-
2023 Will Go Down As The Year Pharma Showed Its Determination To Beat Cancer
Friday, December 29, 2023 - 1:48pm | 838Read More...During the last week of 2023, AstraZeneca PLC (NASDAQ: AZN) agreed to acquire Chinese cancer therapy developer Gracell Biotechnologies Inc. as it continues its efforts to tap pharma innovations from China’s biotech industry. Although this year, Covid-19 stars, namely Pfizer Inc (...
-
Psychedelics Producer Lucy Scientific Discovery Partners With Pramantha Group For Funding: What's Next?
Friday, March 17, 2023 - 3:38pm | 349Read More...Early-stage psychedelics manufacturing company Lucy Scientific Discovery Inc. (NASDAQ: LSDI) partnered with specialized firm Pramantha Group to obtain key government contracts and grants that would enhance its drug manufacturing capabilities to meet the growing demand. See Also: Lucy...
-
Express Scripts Confirms It's Working With Sen. Wyden's Bill
Wednesday, March 15, 2017 - 1:32pm | 354Read More...Express Scripts Holding Company (NASDAQ: ESRX) saw its stock lose nearly 2 percent Wednesday after Sen. Ron Wyden proposed a legislation which would require drug middlemen, like Express Scripts, from disclosing otherwise secret discounts they receive from drug manufacturers. According to a...
-
Top 4 Large-Cap Stocks In The Drug Manufacturers Industry With The Highest ROE
Monday, April 6, 2015 - 4:46am | 133Read More...Below are the top large-cap drug manufacturers stocks on the NYSE and the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Shire plc (NASDAQ: SHPG) is 50.50%. Shire's PEG ratio is 1.01. The trailing-twelve-month return on equity at GlaxoSmithKline plc (NYSE:...
